MSI1 and colorectal carcinoma: To further determine whether Musashi-1 was sufficient for triggering CRC CD44+ populations, we knocked down Musashi-1 by delivering two specific small interferring RNAs to HT-29/FLAGMusashi-1 cells (Fig. 1C, left panel).